big boost for biota

The European Centre for Disease Prevention and Control this week said Tamiflu, marketed by Swiss pharmaceutical giant Roche, may be losing potency against some of the influenza viruses circulating in the northern hemispheric winter.

Tests on 148 samples of influenza viruses isolated during November and December from 10 European countries found 19 "showed evidence of resistance to oseltamivir" (the generic name for Tamiflu).

http://business.theage.com.au/big-boost-for-antiflu-drug-developer/20080131-1pd3.html